These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24385069)

  • 1. Impact of chronic obstructive pulmonary disease on patient with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Sung PH; Chung SY; Sun CK; Yang CH; Chen SM; Hang CL; Chen CJ; Yeh KH; Chen YL; Wu CJ; Chang HW; Tsai TH; Yip HK
    Biomed J; 2013; 36(6):274-81. PubMed ID: 24385069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic role of chronic obstructive pulmonary disease in ST-elevation myocardial infarction after primary angioplasty.
    Lazzeri C; Valente S; Attanà P; Chiostri M; Picariello C; Gensini GF
    Eur J Prev Cardiol; 2013 Jun; 20(3):392-8. PubMed ID: 22023803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chronic obstructive pulmonary diseases on outcomes and hospital days after percutaneous coronary intervention.
    Zhang JW; Zhou YJ; Yang Q; Yang SW; Nie B; Xu XH
    Angiology; 2013 Aug; 64(6):430-4. PubMed ID: 22942128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of anaemia in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Bolińska S; Sobkowicz B; Zaniewska J; Chlebińska I; Boliński J; Milewski R; Tycińska A; Musiał W
    Kardiol Pol; 2011; 69(1):33-9. PubMed ID: 21267962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction.
    Wakabayashi K; Gonzalez MA; Delhaye C; Ben-Dor I; Maluenda G; Collins SD; Syed AI; Gaglia MA; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2010 Aug; 106(3):305-9. PubMed ID: 20643237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention.
    Campo G; Guastaroba P; Marzocchi A; Santarelli A; Varani E; Vignali L; Sangiorgio P; Tondi S; Serenelli C; De Palma R; Saia F
    Chest; 2013 Sep; 144(3):750-757. PubMed ID: 23392738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of successful staged revascularization of a chronic total occlusion in the non-infarct-related artery on long-term outcome in patients with acute ST-segment elevation myocardial infarction.
    Yang ZK; Zhang RY; Hu J; Zhang Q; Ding FH; Shen WF
    Int J Cardiol; 2013 Apr; 165(1):76-9. PubMed ID: 21872352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Zhang JW; Zhou YJ; Cao SJ; Yang Q; Yang SW; Nie B
    Coron Artery Dis; 2013 Aug; 24(5):352-6. PubMed ID: 23835666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on- versus off-hours (a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial substudy).
    Cubeddu RJ; Palacios IF; Blankenship JC; Horvath SA; Xu K; Kovacic JC; Dangas GD; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Stone GW; Mehran R
    Am J Cardiol; 2013 Apr; 111(7):946-54. PubMed ID: 23340031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staged versus one-time complete revascularization with percutaneous coronary intervention for multivessel coronary artery disease patients without ST-elevation myocardial infarction.
    Hannan EL; Samadashvili Z; Walford G; Jacobs AK; Stamato NJ; Venditti FJ; Holmes DR; Sharma S; King SB
    Circ Cardiovasc Interv; 2013 Feb; 6(1):12-20. PubMed ID: 23322743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials.
    Karrowni W; Vyas A; Giacomino B; Schweizer M; Blevins A; Girotra S; Horwitz PA
    JACC Cardiovasc Interv; 2013 Aug; 6(8):814-23. PubMed ID: 23968700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year clinical outcomes of ST segment elevation myocardial infarction patients treated with emergent percutaneous coronary intervention: the impact of thrombus burden.
    Tungsubutra W; Towashiraporn K; Tresukosol D; Chotinaiwattrakul C; Phankingthongkum R; Wongpraparut N; Panchavinnin P
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S139-46. PubMed ID: 24772591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ST-elevation myocardial infarction in the elderly--temporal trends in incidence, utilization of percutaneous coronary intervention and outcomes in the United States.
    Khera S; Kolte D; Palaniswamy C; Mujib M; Aronow WS; Singh T; Gotsis W; Silverman G; Frishman WH
    Int J Cardiol; 2013 Oct; 168(4):3683-90. PubMed ID: 23838593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Zhao L; Wang L; Zhang Y
    J Invasive Cardiol; 2009 Oct; 21(10):493-8. PubMed ID: 19805833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.